DBCCF
Decibel Cannabis Company Inc.·Healthcare
0.08
9.068%(−0.01)
Close PriceLast Updated: — ET
52W L: $0.0452W H: $0.11
DBCCF NEWS
prnewswire.com
May 21
Decibel Reports First Quarter 2026 Results: Quarterly Revenue Grows 41% YoY to $30 Million, Issues Q2 2026 Guidance
CALGARY, AB, May 21, 2026 /PRNewswire/ - Decibel Cannabis Company Inc. (the "Company" or "Decibel") (TSXV: DB) (OTCQB: DBCCF), a market leader in Canadian branded cannabis manufactured products and global medical exports, today announced its financial results for the three month period ended March 31, 2026. "Q1 was a strong start to the year with revenue up 41%, international sales tripling and Adjusted EBITDA doubling year over year.
prnewswire.com
May 13
Decibel to Announce First Quarter 2026 Financial Results on May 21, 2026
CALGARY, AB, May 13, 2026 /PRNewswire/ - Decibel Cannabis Company Inc. (the "Company" or "Decibel") (TSXV: DB) (OTCQB: DBCCF), a market leader in Canadian branded cannabis manufactured products and global medical exports, announces that it will report its first quarter 2026 financial results pre-market on Thursday, May 21, 2026. The Company will host a live conference call to discuss the results at 10:00 a.m.
prnewswire.com
Apr 16
Decibel Reports Full-Year and Fourth Quarter 2025 Results: Revenue Grows 22% to $113 Million, Issues 2026 Guidance
CALGARY, AB, April 16, 2026 /PRNewswire/ - Decibel Cannabis Company Inc. (the "Company" or "Decibel") (TSXV: DB) (OTCQB: DBCCF), a leading Canadian branded cannabis company with a growing international platform, today announced its audited financial results for the three and twelve month periods ended December 31, 2025. "Our 2025 performance tells a compelling story with 22% revenue growth, $23 million of Adjusted EBITDA and Free Cash Flow up almost 3x from last year.
prnewswire.com
Apr 8
Decibel to Announce Fourth Quarter 2025 Financial Results on April 16, 2026
CALGARY, AB, April 8, 2026 /PRNewswire/ - Decibel Cannabis Company Inc. (the "Company" or "Decibel") (TSXV: DB) (OTCQB: DBCCF), a market leader in Canadian branded cannabis manufactured products and global medical exports, announces that it will report its fourth quarter 2025 financial results pre-market on Thursday, April 16, 2026. The Company will host a live conference call to discuss the results at 10:00 a.m.
